Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage

Journal of the American Society of Nephrology

Volumn 22, Issue 9, 2011, Pages 1682-1695

  Loureiro, Jesús ^a   Aguilera, Abelardo ^a   Selgas, Rafael ^b   Sandoval, Pilar ^a   Albar Vizcaíno, Patricia ^a   Pérez Lozano, María Luisa ^a   Ruiz Carpio, Vicente ^a   Majano, Pedro L ^a,c   Lamas, Santiago ^d   Rodríguez Pascual, Fernando ^d   Borras Cuesta, Francisco ^e   Dotor, Javier ^f   López Cabrera, Manuel ^a,c,d  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^e UNIVERSITY OF NAVARRA   (Spain)

^f Digna Biotech   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CALVASCULIN; CYTOKERATIN; PROTEIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1 BLOCKING PEPTIDE P144; TRANSFORMING GROWTH FACTOR BETA1 BLOCKING PEPTIDE P17; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; FIBROBLAST; GENE TRANSFER; MESOTHELIAL TO MESENCHYMAL TRANSITION; MOUSE; NONHUMAN; PERITONEAL DIALYSIS; PERITONITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 80052313093     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010111197     Document Type: Article

References (51)

1. Krediet R.T.: The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 55: 341-356, 1999
2. Krediet R.T., Lindholm B., Rippe B.: Pathophysiology of peritoneal membrane failure. Perit Dial Int 20[Suppl 4]: S22-S42, 2000
3. Aroeira L.S., Aguilera A., Sanchez-Tomero J.A., Bajo M.A., Del Peso G., Jimenez Heffernan JA, Selgas R, Lopez-Cabrera M: Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: Pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18: 2004-2013, 2007 (Pubitemid 47041064)
4. Yung S., Chan T.M.: Intrinsic cells: Mesothelial cells-Central players in regulating inflammation and resolution. Perit Dial Int 29[Suppl 2]: S21-S27, 2009
5. Selgas R., Fernandez-Reyes M.J., Bosque E., Bajo M.A., Borrego F., Jimenez C., Del Peso G., De Alvaro F.: Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 23: 64-73, 1994 (Pubitemid 24021750)
6. Williams J.D., Craig K.J., Topley N., Von Ruhland C., Fallon M., Newman G.R., Mackenzie R.K., Williams G.T.: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479, 2002 (Pubitemid 34106290)
7. Mateijsen M.A., Van der Wal A.C., Hendriks P.M., Zweers M.M., Mulder J., Struijk D.G., Krediet R.T.: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19: 517-525, 1999 (Pubitemid 30015564)
8. Plum J., Hermann S., Fusshöller A., Schoenicke G., Donner A., Rohrborn A, Grabensee B: Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int Suppl 78: S42-S47, 2001 (Pubitemid 32144068)
9. Margetts P.J., Bonniaud P.: Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 23: 530-541, 2003 (Pubitemid 37527296)
10. Devuyst O., Margetts P.J., Topley N.: The pathophysiology of the peritoneal membrane. J Am Soc Nephrol 21: 1077-1085, 2010
11. Yáñez-Mo M., Lara-Pezzi E., Selgas R., Ramírez-Huesca M., Domínguez- Jiménez C, Jiménez-Heffernan JA, Aguilera A, Sánchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sánchez-Madrid F, López-Cabrera M: Peritoneal dialysis and epithelial- to-mesenchymal transition of mesothelial cells. N Engl J Med 348: 403-413, 2003
12. Jiménez-Heffernan J.A., Aguilera A., Aroeira L.S., Lara-Pezzi E., Bajo M.A., Del Peso G., Ramírez M., Gamallo C., Sanchez-Tomero J.A., Alvarez V., López-Cabrera M., Selgas R.: Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch 444: 247-256, 2004 (Pubitemid 38446437)
13. Yang A.H., Chen J.Y., Lin J.K.: Myofibroblastic conversion of mesothelial cells. Kidney Int 63: 1530-1539, 2003 (Pubitemid 36350019)
14. Aguilera A., Yáñez-Mo M., Selgas R., Sánchez-Madrid F., López-Cabrera M.: Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Investig Drugs 6: 262-268, 2005 (Pubitemid 40424734)
15. Aroeira L.S., Aguilera A., Selgas R., Ramírez-Huesca M., Pérez-Lozano M.L., Cirugeda A., Bajo M.A., Del Peso G., Sánchez-Tomero J.A., Jimenez- Heffernan JA, López-Cabrera M: Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor. Am J Kidney Dis 46: 938-948, 2005 (Pubitemid 41505470)
16. Aroeira L.S., Lara-Pezzi E., Loureiro J., Aguilera A., Ramírez-Huesca M., González-Mateo G., Pérez-Lozano M.L., Albar-Vizcaíno P., Bajo M.A., Del Peso G., Sánchez-Tomero J.A., Jiménez-Heffernan J.A., Selgas R., López- Cabrera M: Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane. J Am Soc Nephrol 20: 582-592, 2009
17. Del Peso G., Jiménez-Heffernan J.A., Bajo M.A., Aroeira L.S., Aguilera A., Fernández-Perpén A., Cirugeda A., Castro M.J., De Gracia R., Sánchez- Villanueva R, Sánchez-Tomero JA, López-Cabrera M, Selgas R: Epithelial- to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int Suppl 108: S26-S33, 2008 (Pubitemid 351466514)
18. Mizutani M., Ito Y., Mizuno M., Nishimura H., Suzuki Y., Hattori R., Matsukawa Y., Imai M., Oliver N., Goldschmeding R., Aten J., Krediet R.T., Yuzawa Y., Matsuo S.: Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol 298: F721-F733, 2010
19. Zeisberg E.M., Potenta S.E., Sugimoto H., Zeisberg M., Kalluri R.: Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19: 2282-2287, 2008
20. Li J., Qu X., Bertram J.F.: Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 175: 1380-1388, 2009
21. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., Chandraker A., Yuan X., Pu W.T., Roberts A.B., Neilson E.G., Sayegh M.H., Izumo S., Kalluri R.: Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961, 2007 (Pubitemid 47222040)
22. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G.: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002 (Pubitemid 34847966)
23. Sakai N., Wada T., Yokoyama H., Lipp M., Ueha S., Matsushima K., Kaneko S.: Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103: 14098-14103, 2006 (Pubitemid 44452986)
24. Bellini A., Mattoli S.: The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 87: 858-870, 2007 (Pubitemid 47267815)
25. Border W.A., Noble N.A.: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994 (Pubitemid 24333194)
26. Shi Y., Massagué J.: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003 (Pubitemid 36724933)
27. Xu J., Lamouille S., Derynck R.: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172, 2009
28. López-Novoa J.M., Nieto M.A.: Inflammation and EMT: An alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1: 303-314, 2009
29. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G.: Transforming growth factor-≲βτα∀1 induces ≲αλπη α∀-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblast. J Cell Biol 122: 103-111, 1993 (Pubitemid 23188802)
30. Lai K.N., Lai K.B., Lam C.W., Chan T.M., Li F.K., Leung J.C.: Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 35: 644-652, 2000 (Pubitemid 30185509)
31. Gangji A.S., Brimble K.S., Margetts P.J.: Association between markers of inflammation, fibrosis and hypervolemia in peritoneal dialysis patients. Blood Purif 28: 354-358, 2009
32. Yao Q., Pawlaczyk K., Ayala E.R., Styszynski A., Breborowicz A., Heimburger O., Qian J.Q., Stenvinkel P., Lindholm B., Axelsson J.: The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron Exp Nephrol 109: e71-e78, 2008
33. Margetts P.J., Kolb M., Galt T., Hoff C.M., Shockley, T.R. Gauldie J.: Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function. J Am Soc Nephrol 12: 2029-2039, 2001 (Pubitemid 32880339)
34. Margetts P.J., Bonniaud P., Liu L., Hoff C.M., Holmes C.J., West-Mays, J.A. Kelly M.M.: Transient overexpression of TGF- ≲βτα∀1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16: 425-436, 2005 (Pubitemid 41725138)
35. Patel P., Sekiguchi Y., Oh K.H., Patterson S.E., Kolb M.R., Margetts P.J.: Smad3-dependent and -independent pathways are involved in peritoneal membrane injury. Kidney Int 77: 319-328, 2010
36. Guo H., Leung J.C., Lam M.F., Chan L.Y., Tsang A.W., Lan H.Y., Lai K.N.: Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis. J Am Soc Nephrol 18: 2689-2703, 2007 (Pubitemid 47531196)
37. Nie J., Dou X., Hao W., Wang X., Peng W., Jia Z., Chen W., Li X., Luo N., Lan H.Y., Yu X.Q.: Smad7 gene transfer inhibits peritoneal fibrosis. Kidney Int 72: 1336-1344, 2007 (Pubitemid 350126775)
38. Sun Y., Zhu F., Yu X., Nie J., Huang F., Li X., Luo N., Lan H.Y., Wang Y.: Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis. Am J Nephrol 30: 84-94, 2009
39. Loureiro J., Schilte M., Aguilera A., Albar-Vizcaíno P., Ramírez-Huesca M., Pérez-Lozano M.L., González-Mateo G., Aroeira L.S., Selgas R., Mendoza L., Ortiz A., Ruíz-Ortega M., Van den Born J., Beelen R.H., López-Cabrera M.: BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrol Dial Transplant 25: 1098-1108, 2010
40. Yu M.A., Shin K.S., Kim J.H., Kim Y.I., Chung S.S., Park S.H., Kim Y.L., Kang D.H.: HGF and BMP-7 ameliorate high glucose-induced epithelial-to- mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol 20: 567-581, 2009
41. Zhu F., Li T., Qiu F., Fan J., Zhou Q., Ding X., Nie J., Yu X.: Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats. Am J Pathol 176: 650-659, 2010
42. Dotor J., López-Vázquez A.B., Lasarte J.J., Sarobe P., García-Granero M., Riezu-Boj J.I., Martínez A., Feijoó E.,López-Sagaseta J., Hermida J., Prieto J., Borrá s-Cuesta F: Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library. Cytokine 39: 106-115, 2007 (Pubitemid 47513834)
43. Ezquerro I.J., Lasarte J.J., Dotor J., Castilla-Cortázar I., Bustos M., Pen ̈uelas I, Blanco G, Rodríguez C, Lechuga Mdel C, Greenwel P, Rojkind M, Prieto J, Borrá s-Cuesta F: A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine 22: 12-20, 2003 (Pubitemid 37222298)
44. Hermida N., López B., González A., Dotor J., Lasarte J.J., Sarobe P., Borrás-Cuesta F., Díez J.: A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Cardiovasc Res 81: 601-609, 2009
45. Santiago B., Gutierrez-Cañas I., Dotor J., Palao G., Lasarte J.J., Ruiz J., Prieto J., Borrás-Cuesta F., Pablos J.L.: Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycininduced skin fibrosis. J Invest Dermatol 125: 450-455, 2005
46. Sandoval P., Loureiro J., González-Mateo G., Pérez-Lozano M.L., Maldonado-Rodríguez A., Sánchez-Tomero J.A., Mendoza L., Santamaría B., Ortiz A., Ruíz-Ortega M., Selgas R., Martín P., Sánchez- Madrid F, Aguilera A, López-Cabrera M: PPAR-≲γαμμα∀ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab Invest 90: 1517-1532, 2010
47. Yoshimura A., Wakabayashi Y., Mori T.: Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem 147: 781-792, 2010
48. Wang X., Nie J., Jia Z., Feng M., Zheng Z., Chen W., Li X., Peng W., Zhang S., Sun L., Mao H., Lan H.Y., Yu X.: Impaired TGF-beta signalling enhances peritoneal inflammation induced by E. coli in rats. Nephrol Dial Transplant 25: 399-412, 2010
49. Otsuka G., Agah R., Frutkin A.D., Wight T.N., Dichek D.A.: Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways. Arterioscler Thromb Vasc Biol 26: 737-743, 2006 (Pubitemid 43732145)
50. González-Mateo G.T., Loureiro J., Jiménez-Hefferman J.A., Bajo M.A., Selgas R., López-Cabrera M., Aroeira L.S.: Chronic exposure of mouse peritoneum to peritoneal dialysis fluid: Structural and functional alterations of the peritoneal membrane. Perit Dial Int 29: 227-230, 2009
51. Gil-Guerrero L., Dotor J., Huibregtse I.L., Casares N., López-Vázquez A.B., Rudilla F., Riezu-Boj J.I., López-Sagaseta J., Hermida J., Van Deventer S., Bezunartea J., Llopiz D., Sarobe P., Prieto J., Borrás-Cuesta F., Lasarte J.J.: In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1. J Immunol 181: 126-135, 2008